| 000 | 01394 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250517202548.0 | ||
| 264 | 0 | _c20181220 | |
| 008 | 201812s 0 0 eng d | ||
| 022 | _a1744-8042 | ||
| 024 | 7 |
_a10.2217/pgs-2017-0157 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aXutao, Guo | |
| 245 | 0 | 0 |
_aBCL11A and MDR1 expressions have prognostic impact in patients with acute myeloid leukemia treated with chemotherapy. _h[electronic resource] |
| 260 |
_bPharmacogenomics _c03 2018 |
||
| 300 |
_a343-348 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aATP Binding Cassette Transporter, Subfamily B _xgenetics |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aCarrier Proteins _xgenetics |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukemia, Myeloid, Acute _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNuclear Proteins _xgenetics |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aRemission Induction _xmethods |
| 650 | 0 | 4 | _aRepressor Proteins |
| 700 | 1 | _aPengCheng, Shi | |
| 700 | 1 | _aYin, Li | |
| 700 | 1 | _aHuijuan, Dong | |
| 700 | 1 | _aYan, Wang | |
| 700 | 1 | _aHaiqing, Zheng | |
| 700 | 1 | _aBing, Xu | |
| 773 | 0 |
_tPharmacogenomics _gvol. 19 _gno. 4 _gp. 343-348 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2217/pgs-2017-0157 _zAvailable from publisher's website |
| 999 |
_c28111477 _d28111477 |
||